{"id":"NCT00141921","sponsor":"Amgen","briefTitle":"Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis","officialTitle":"An Open-Label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects With Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08-11","primaryCompletion":"2011-12-19","completion":"2017-08-16","firstPosted":"2005-09-02","resultsPosted":"2017-02-10","lastUpdate":"2017-10-05"},"enrollment":182,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pediatric Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Etanercept","otherNames":["EnbrelÂ®"]}],"arms":[{"label":"Etanercept","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the long-term safety and efficacy of etanercept in pediatric patients with moderate to severe psoriasis.","primaryOutcome":{"measure":"Number of Participants With Adverse Events","timeFrame":"264 Weeks","effectByArm":[{"arm":"Etanercept","deltaMin":161,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20605256","26775775"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":181},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Headache","Acne","Pharyngitis streptococcal"]}}